{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:10:20Z","timestamp":1790514620437,"version":"4.1.0"},"reference-count":24,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Recently, a range of prescription and over-the-counter (OTC) drugs have emerged as being used recreationally, either on their own or in combination with other substances, both licit and illicit, including new psychoactive substances (NPS). Among them, the misuse of prescription drugs involves not only traditionally recorded substances, such as benzodiazepines and opioid pain relievers, but also gabapentinoids (e.g., pregabalin and gabapentin); some antidepressants, e.g., bupropion and venlafaxine; some second-generation antipsychotics, e.g., quetiapine and olanzapine. Moreover, the use of some OTC for recreational purposes appears on the increase, especially in vulnerable categories such as young people\/youths, including the use of high dosages of the antidiarrheal loperamide; first-generation antihistamines, e.g., promethazine, cyclizine, and diphenhydramine; cough and cold preparations containing dextromethorphan and\/or codeine. In this context, the role of the Internet has rapidly increased, playing a significant role both in the diffusion of emerging trends of drug misuse among users and experimenters, and the marketing, sale, and distribution of drugs through online pharmacies. This phenomenon within the context of a rapidly modifying drug scenario is a globally recognized health problem, determining severe adverse consequences, including fatalities, and represents a challenge for clinicians in general, psychiatrists, public health, and drug-control policies.<\/jats:p>","DOI":"10.3390\/brainsci10100736","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T08:59:22Z","timestamp":1602665962000},"page":"736","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["What about \u201cPharming\u201d? Issues Regarding the Misuse of Prescription and Over-the-Counter Drugs"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6810-1540","authenticated-orcid":false,"given":"Stefania","family":"Chiappini","sequence":"first","affiliation":[{"name":"Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hertfordshire AL10 9AB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4178-5401","authenticated-orcid":false,"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hertfordshire AL10 9AB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MOP.0b013e32814b09cf","article-title":"\u201cPharming\u201d: The abuse of prescription and over-the-counter drugs in teens","volume":"19","author":"Levine","year":"2007","journal-title":"Curr. Opin. Paediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14423\/SMJ.0000000000000256","article-title":"Abuse of medications that theoretically are without abuse potential","volume":"108","author":"Reeves","year":"2015","journal-title":"South. Med. J."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Schifano, F. (2018). Recent Changes in Drug Abuse Scenarios: The New\/Novel Psychoactive Substances (NPS) Phenomenon. Brain Sci., 8.","DOI":"10.3390\/brainsci8120221"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Schifano, F., Chiappini, S., Corkery, J.M., and Guirguis, A. (2018). Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review. Brain Sci., 8.","DOI":"10.3390\/brainsci8040073"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000507897","article-title":"Coming off prescribed psychotropic medications: Insights from their use as recreational drugs","volume":"89","author":"Schifano","year":"2020","journal-title":"Psychother. Psychosom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13722-019-0170-4","article-title":"Staff perceptions of prescription and over-the-counter drug dependence services in England: A qualitative study","volume":"14","author":"Coombes","year":"2019","journal-title":"Addict. Sci. Clin. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3122\/jabfm.2008.01.070071","article-title":"Abuse of prescription and over-the-counter medications","volume":"21","author":"Lessenger","year":"2008","journal-title":"J. Am. Board Fam. Med."},{"key":"ref_8","unstructured":"Lipari, R.N., Williams, M., and Van Horn, S.L. (2020, September 19). Why do Adults Misuse Prescription Drugs? The CBHSQ Report: 27 July 2017. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD, Available online: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/report_3210\/ShortReport-3210.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/cyber.2014.0486","article-title":"Mind navigators of chemicals\u2019 experimenters? A web-based description of e-psychonauts","volume":"18","author":"Orsolini","year":"2015","journal-title":"Cyberpsychol. Behav. Soc. Netw."},{"key":"ref_10","unstructured":"Hughes, A., Williams, M.R., Lipari, R.N., Bose, J., Copello, E.A.P., and Kroutil, L.A. (2020, September 19). Prescription Drug Use and Misuse in the United States: Results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review. September 2016, Available online: https:\/\/samhsa.gov\/data."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.drugpo.2017.11.003","article-title":"The diverse reasons for using Novel Psychoactive Substances\u2014A qualitative study of the users\u2019 own perspectives","volume":"52","author":"Soussan","year":"2018","journal-title":"Int. J. Drug Policy"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1080\/17512433.2016.1178571","article-title":"The consequences of drug misuse on post-marketing surveillance","volume":"9","author":"Schifano","year":"2016","journal-title":"Exp. Rev. Clin. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Alomar, M., Tawfiq, A.M., Hassan, N., and Palaian, S. (2020). Post marketing surveillance of suspected adverse drug reactions through spontaneous reporting: Current status, challenges and the future. Therap. Adv. Drug Saf.","DOI":"10.1177\/2042098620938595"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.drugalcdep.2009.08.006","article-title":"Risk management post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert panel report","volume":"105","author":"Johanson","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Novak, S.P., H\u00e5kansson, A., Martinez-Raga, J., Reimer, J., Krotki, K., and Varughese, S. (2016). Nonmedical use of prescription drugs in the European Union. BMC Psychiatry, 16.","DOI":"10.1186\/s12888-016-0909-3"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMp1806486","article-title":"The FDA and the next wave of drug abuse\u2014Proactive pharmacovigilance","volume":"379","author":"Throckmorton","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_17","unstructured":"Medicines and Healthcare Products Regulatory Agency\u2014Gov.uk (MHRA) (2020, September 19). Yellow Card Scheme, Available online: https:\/\/yellowcard.mhra.gov.uk."},{"key":"ref_18","unstructured":"(2020, September 19). European Medicines Agency (EMA) Guideline on Good Pharmacovigilance Practices (GVP) Annex I\u2014Definitions (Rev 4) (2017). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-good-pharmacovigilance-practices-annex-i-definitions-rev-4_en.pdf."},{"key":"ref_19","first-page":"1","article-title":"New\/emerging psychoactive substances and associated psychopathological consequences","volume":"87","author":"Schifano","year":"2019","journal-title":"Psychol. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/bmb\/ldw016","article-title":"Digital danger: A review of the global public health, patient safety and cybersecurity threats posed by illicit online pharmacies","volume":"118","author":"Mackey","year":"2016","journal-title":"Br. Med. Bull."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2573","DOI":"10.1002\/hup.2573","article-title":"An insight into the deep web; why it matters for addiction psychiatry?","volume":"32","author":"Orsolini","year":"2017","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.psychres.2017.11.037","article-title":"Searching online to buy commonly prescribed psychiatric drugs","volume":"260","author":"Monteith","year":"2018","journal-title":"Psychiatry Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0043-102059","article-title":"New Psychoactive Substances (NPS)\u2014A Challenge for the Addiction Treatment Services","volume":"50","author":"Scherbaum","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fingleton, N., Duncan, E., Watson, M., and Matheson, C. (2019). Specialist clinicians\u2019 management of dependence on non-prescription medicines and barriers to treatment provision: An exploratory mixed methods study using behavioural theory. Pharmacy, 7.","DOI":"10.3390\/pharmacy7010025"}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/10\/10\/736\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:21:02Z","timestamp":1760178062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/10\/10\/736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["brainsci10100736"],"URL":"https:\/\/doi.org\/10.3390\/brainsci10100736","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]}}}